EFS
KRRO icon

Essex Financial Services’s Korro Bio KRRO Stock Holding History

Essex Financial Services’s Portfolio KRRO Stock Details KRRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-400
Closed -$7.4K – 516
2023
Q3 		$7.4K Hold
400
– – ﹤0.01% 471
2023
Q2 		$6.92K Hold
400
– – ﹤0.01% 473
2023
Q1 		$10.1K Hold
400
– – ﹤0.01% 483
2022
Q4 		$77K Hold
400
– – 0.01% 469
2022
Q3 		$36K Hold
400
– – ﹤0.01% 454
2022
Q2 		$30K Buy
+400
New +$27K ﹤0.01% 477

Other funds holding KRRO

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
QUSVM
Qiming U.S. Ventures Management Bellevue, Washington $55.6M AUM 98.09% 1-Year Est. Return
7IH
72 Investment Holdings Stamford, Connecticut $49.6M AUM 684.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Essex Financial Services's KRRO Position: Q4 2023 in Review

Essex Financial Services sold out of Korro Bio (KRRO) in Q4 2023, closing a stake of 400 shares — an estimated $7.4K sold.

Essex Financial Services first reported a position in KRRO in Q2 2022 and held it in 6 quarters. The position peaked at $77K in Q4 2022. 40 funds tracked by Wall St. Rank hold KRRO as of Q4 2023.

  • Essex Financial Services reported no remaining Korro Bio position as of Q4 2023 after selling out during the quarter.
  • Essex Financial Services sold 400 Korro Bio shares in Q4 2023, an estimated $7.4K.
  • Essex Financial Services first reported a position in Korro Bio in Q2 2022 and held it in 6 quarters.
  • Essex Financial Services's Korro Bio position peaked at $77K in Q4 2022.
  • 40 funds tracked by Wall St. Rank held Korro Bio as of Q4 2023.

Based on Essex Financial Services's 13F filing for Q4 2023, filed 6 Feb 2024.